Intraday BUY SELL Signals
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
GINX vs GSK
GINX vs GSK Comparison
Open Charts GINX vs GSK
SGI Enhanced Global Income ETF
Price$30.39
Change-$0.16 (-0.52%)
Volume$247
Net Assets79.69M
GINX vs GSK Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
GINX vs. GSK commentary
Nov 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GINX is a Buy and GSK is a Buy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 40 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 41 | |
P/E GROWTH RATING 1..100 | 88 | |
SEASONALITY SCORE 1..100 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| GINX | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 48% |
| Stochastic ODDS (%) | 2 days ago 70% | 2 days ago 42% |
| Momentum ODDS (%) | 2 days ago 87% | 2 days ago 70% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 58% |
| TrendWeek ODDS (%) | 2 days ago 88% | 2 days ago 62% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 56% |
| Advances ODDS (%) | 2 days ago 89% | 3 days ago 60% |
| Declines ODDS (%) | 10 days ago 62% | 29 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 49% |
| Aroon ODDS (%) | 2 days ago 81% | 2 days ago 48% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BRKU | 25.45 | 0.51 | +2.04% |
| Direxion Daily BRKB Bull 2X Shares | |||
| AVGV | 71.71 | 0.35 | +0.50% |
| Avantis All Equity Markets Value ETF | |||
| VMO | 9.75 | N/A | N/A |
| Invesco Municipal Opportunity Trust | |||
| GEMD | 42.72 | -0.02 | -0.04% |
| Goldman Sachs Access Emrg Mkts USD BdETF | |||
| VTWO | 98.48 | -0.26 | -0.26% |
| Vanguard Russell 2000 ETF | |||
GINX and
Correlation & Price change
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
|---|---|---|---|---|
| GINX | 100% | +0.46% | ||
| GSK - GINX | 25% Poorly correlated | -0.70% | ||
| FMS - GINX | 23% Poorly correlated | -0.17% | ||
| SMFG - GINX | 23% Poorly correlated | +1.09% | ||
| SONY - GINX | 23% Poorly correlated | +3.77% | ||
| RELX - GINX | 23% Poorly correlated | -2.64% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y